Nasogastric Tube Market Expected to Reach $693.09 Million by 2035

According to a new report published by Allied Market Research, titled, “Nasogastric Tube Market," The nasogastric tube market was valued at $401.95 million in 2023, and is estimated to reach $693.1 million by 2035, growing at a CAGR of 4.6% from 2024 to 2035.

The rising prevalence of chronic illnesses like cancer, stroke, and other neurological disorders has increased the need for nasogastric tubes in hospitals and homecare settings. These conditions often result in difficulty swallowing, making nasogastric tubes a critical tool for maintaining nutrition and hydration. Additionally, the growing aging population, with its associated increase in healthcare needs, has further fueled the demand for these devices, driving the nasogastric tube market size.

Furthermore, the shift toward patient-centric care has also driven advancements in nasogastric tube technology. Features such as improved material biocompatibility, and radiopaque markers for accurate placement have enhanced user safety and comfort, leading to greater acceptance in both clinical and outpatient environments. Increased investments in healthcare infrastructure globally have further contributed to nasogastric tube market growth.

Expanding applications in pediatric and neonatal care also serve as significant growth drivers. Premature and critically ill infants often require precise nutritional support, and nasogastric tubes provide an effective solution for these vulnerable populations. The rise in neonatal intensive care units (NICUs) worldwide has directly boosted the adoption of these devices, further driving nasogastric tube market growth.

The nasogastric tube market is segmented into type, application, end user, and region. Depending on type, it is further categorized into levin tube, Salem sump tube, and others. The levin tube segment dominated the nasogastric tube market share in 2023 as it is widely used for feeding, medication delivery, and gastric decompression in both acute and chronic care. Its affordability, ease of manufacturing, and broad application in general medical and surgical care make it the dominant revenue generator. Hospitals and clinics prefer Levin Tubes for routine use, which drives the consistent demand. However, Salem Sump tube is expected to register the highest CAGR during the forecast period. This is attributed to increase in demand for advanced tubes, due to the double-lumen design, which offers advanced functionality for gastric drainage and venting.

By application, the market is fragmented into neurological disorders, cancer, and others. The neurological disorders segment dominated the nasogastric tube market share in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to the rising prevalence of disorders like strokes and neurodegenerative diseases that impair swallowing, coupled with increased awareness of nutritional support's importance in managing neurological disorders, necessitating long-term nasogastric tube use.

By end user, the market is segregated into hospitals, home care, and others. The hospital segment dominated the nasogastric tube market size in 2023 due to the high volume of acute care and critical care procedures requiring nasogastric tubes. The centralized purchase of medical supplies, the availability of trained professionals for insertion, and the constant need for NG tubes for inpatients make hospitals the primary revenue generator.

However, home care segment is expected to register the highest CAGR during the forecast period. Due to the increasing shift towards home-based care and the rising adoption of telemedicine, the demand in home care settings is growing rapidly and these are also the nasogastric tube market trends. Patients with chronic illnesses or recovering from surgeries are increasingly managed at home, reducing hospital stays.

Region wise,  North America was the largest shareholder in the global nasogastric tube market in 2023, owing to its advanced healthcare infrastructure, higher healthcare expenditure, and widespread adoption of medical devices like nasogastric tubes. The region has a significant prevalence of chronic illnesses, such as cancer and neurological disorders, requiring enteral feeding solutions. Furthermore, the presence of leading manufacturers and favorable reimbursement policies ensures consistent revenue generation abd nasogastric tube market opportunity.

Asia-Pacific is projected to grow at the highest CAGR due to the rising healthcare needs in densely populated countries like China and India. Increasing awareness about enteral feeding, expanding healthcare infrastructure, and growing geriatric populations contribute to nasogastric tube market forecast. Additionally, economic development in emerging economies, along with government initiatives to improve healthcare accessibility, supports rapid adoption of nasogastric tubes in the region.

Key Findings of the Study 

• By type, the Levin segment was the largest contributor to the nasogastric tube industry in 2023 and Salem sump tube is expected to register the highest CAGR during the forecast period. 
• By application, the neurological disorders segment was largest contributor to the market in 2023 and is also expected to register the highest CAGR during the forecast period.
• By end user, the hospitals segment dominated the nasogastric tube industry in 2023 and home care segment is expected to grow at a highest CAGR during the forecast period.
• Region wise, North America generated the largest revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.